Tag Archives: clls

Blood-Cancer Fighters To Strut Their Stuff At ASH

One of the biggest medical meetings of the year is this weekend, as the American Society of Hematology (ASH) convenes in Orlando, Fla., to hear about the latest attacks on some of the world’s most intractable blood cancers. Already, some abstracts of presentations released ahead of the conference have made a splash. Tiny French biotech Cellectis (CLLS) will offer details on a case study of an infant with acute lymphoblastic leukemia (ALL) who was

IPO Stock Watch: CAR-T Maker Cellectis Slips In Debut

French biotech Cellectis (CLLS) slipped 5.3% in its Nasdaq debut Wednesday to close at 39.30 after enlarging its deal size to $229 million. Cellectis sold 5.5 million shares at $41.50 each, the price being essentially determined by where the stock was trading on the Alternet market of the Euronext Paris exchange. The company, however, sold 750,000 more shares than it had announced just a day before, when it upped its planned deal size by 50% from